Cargando…

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

OBJECTIVES: We sought to investigate the efficacy and safety of SpikoGen®, a subunit coronavirus disease 2019 (COVID-19) vaccine composed of a recombinant severe acute respiratory syndrome coronavirus 2 spike protein with Advax-CpG55.2™ adjuvant. METHODS: This randomized, placebo-controlled, double-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Kafi, Hamidreza, Fallah, Newsha, Ebrahimi, Ali, Taheri, Ali, Petrovsky, Nikolai, Barati, Saghar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463077/ https://www.ncbi.nlm.nih.gov/pubmed/36096430 http://dx.doi.org/10.1016/j.cmi.2022.09.001

Ejemplares similares

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations
por: Tabarsi, Payam, et al.
Publicado: (2022)

Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical Trial
por: Nafar, Mohsen, et al.
Publicado: (2022)

Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
por: Li, Lei, et al.
Publicado: (2022)

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2023)

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2021)

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
por: Petrovsky, Nikolai, et al.
Publicado: (2015)

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
por: Wanandy, Troy, et al.
Publicado: (2019)

A Phase IV Study of the Safety and Efficacy of CinnoPar(®) in Iranian Patients with Osteoporosis
por: Jamshidi, Ahmadreza, et al.
Publicado: (2021)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
por: Gordon, David L., et al.
Publicado: (2016)

Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis
por: Yousefian, Sahar, et al.
Publicado: (2021)

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2023)

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
por: Komiya, Tomoyoshi, et al.
Publicado: (2021)

Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin
por: Petroski, N.
Publicado: (2017)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
por: Tomar, Jasmine, et al.
Publicado: (2018)

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
por: Lobigs, Mario, et al.
Publicado: (2010)

Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
por: Barati, Saghar, et al.
Publicado: (2021)

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
por: Li, Lei, et al.
Publicado: (2021)

Alzheimer’s disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
por: Davtyan, Hayk, et al.
Publicado: (2016)

Proteomic Study to Survey the CIGB-552 Antitumor Effect
por: Rodríguez-Ulloa, Arielis, et al.
Publicado: (2015)

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021)

552 Predictors Affecting the Quality of Life of Patients with Bronchial Asthma
por: Jankowska-Polanska, Beata, et al.
Publicado: (2012)

SUN-552 Ectopic Thymoma Masquerading as a Thyroid Mass
por: Nagaraja, Soumya
Publicado: (2019)

Complete Genome Sequence of Aeromonas hydrophila Bacteriophage BUCT552
por: Chen, Rujia, et al.
Publicado: (2022)

MicroRNA-552 expression in colorectal cancer and its clinicopathological significance
por: Im, Joon, et al.
Publicado: (2021)

MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1
por: Li, Chao, et al.
Publicado: (2018)

MON-552 Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma
por: Akaishi, Junko, et al.
Publicado: (2019)

miR-552: an important post-transcriptional regulator that affects human cancer
por: Zou, Yuhao, et al.
Publicado: (2020)

miR-552 promotes ovarian cancer progression by regulating PTEN pathway
por: Zhao, Wenman, et al.
Publicado: (2019)

552. Could Anticoagulant Use Prior to Infection with COVID-19 Decrease Mortality?
por: Natali, Kayla M, et al.
Publicado: (2020)

THU552 Understanding Radiation Therapy Sensitivity In Invasive Lobular Carcinoma Of The Breast
por: Boysen, Michael Rhinehart, et al.
Publicado: (2023)

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers
por: Vasan, S, et al.
Publicado: (2009)

Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine
por: Vasan, Sandhya, et al.
Publicado: (2010)

Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar
por: Fatehi, Farzad, et al.
Publicado: (2021)

Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
por: Malekzadeh, Reza, et al.
Publicado: (2020)

CAMAC Dual Fixed Preset Counter (FIPS): (PS-LI 552-002 LE)
por: Knott, J
Publicado: (1984)

miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance
por: Han, Tao, et al.
Publicado: (2020)

552. Within-Host Evaluation of Colonization During Active Methicillin-Resistant S. aureus Bacteremia
por: Berbel Caban, Ana B, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dqekbn2ta73se7iaglte87shgs